Literature DB >> 19801513

PU.1 regulates TCR expression by modulating GATA-3 activity.

Hua-Chen Chang1, Ling Han, Rukhsana Jabeen, Sebastian Carotta, Stephen L Nutt, Mark H Kaplan.   

Abstract

The Ets transcription factor PU.1 is a master regulator for the development of multiple lineages during hematopoiesis. The expression pattern of PU.1 is dynamically regulated during early T lineage development in the thymus. We previously revealed that PU.1 delineates heterogeneity of effector Th2 populations. In this study, we further define the function of PU.1 on the Th2 phenotype using mice that specifically lack PU.1 in T cells using an lck-Cre transgene with a conditional Sfpi1 allele (Sfpi1(lck-/-)). Although deletion of PU.1 by the lck-Cre transgene does not affect T cell development, Sfpi1(lck-/-) T cells have a lower activation threshold than wild-type T cells. When TCR engagement is limiting, Sfpi1(lck-/-) T cells cultured in Th2 polarizing conditions secrete higher levels of Th2 cytokines and have greater cytokine homogeneity than wild-type cells. We show that PU.1 modulates the levels of TCR expression in CD4(+) T cells by regulating the DNA-binding activity of GATA-3 and limiting GATA-3 regulation of TCR gene expression. GATA-3-dependent regulation of TCR expression is also observed in Th1 and Th2 cells. In CD4(+) T cells, PU.1 expression segregates into subpopulations of cells that have lower levels of surface TCR, suggesting that PU.1 contributes to the heterogeneity of TCR expression. Thus, we have identified a mechanism whereby increased GATA-3 function in the absence of the antagonizing activity of PU.1 leads to increased TCR expression, a reduced activation threshold, and increased homogeneity in Th2 populations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19801513      PMCID: PMC2768261          DOI: 10.4049/jimmunol.0900363

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment.

Authors:  W Ouyang; M Löhning; Z Gao; M Assenmacher; S Ranganath; A Radbruch; K M Murphy
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

2.  Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level.

Authors:  G R Lee; P E Fields; R A Flavell
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

3.  T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes.

Authors:  Orly Avni; Dong Lee; Fernando Macian; Susanne J Szabo; Laurie H Glimcher; Anjana Rao
Journal:  Nat Immunol       Date:  2002-06-10       Impact factor: 25.606

4.  Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice.

Authors:  M C Nawijn; R Ferreira; G M Dingjan; O Kahre; D Drabek; A Karis; F Grosveld; R W Hendriks
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

5.  miR-181a is an intrinsic modulator of T cell sensitivity and selection.

Authors:  Qi-Jing Li; Jacqueline Chau; Peter J R Ebert; Giselle Sylvester; Hyeyoung Min; Gwen Liu; Ravi Braich; Muthiah Manoharan; Juergen Soutschek; Petra Skare; Lawrence O Klein; Mark M Davis; Chang-Zheng Chen
Journal:  Cell       Date:  2007-03-22       Impact factor: 41.582

6.  Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage.

Authors:  Michele K Anderson; Angela H Weiss; Gabriela Hernandez-Hoyos; Christopher J Dionne; Ellen V Rothenberg
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

7.  STAT4 requires the N-terminal domain for efficient phosphorylation.

Authors:  Hua-Chen Chang; Shangming Zhang; India Oldham; Lisa Naeger; Timothy Hoey; Mark H Kaplan
Journal:  J Biol Chem       Date:  2003-06-12       Impact factor: 5.157

8.  Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1.

Authors:  Omar D Perez; Dennis Mitchell; Gina C Jager; Sharon South; Chris Murriel; Jacqueline McBride; Lee A Herzenberg; Shigemi Kinoshita; Garry P Nolan
Journal:  Nat Immunol       Date:  2003-10-05       Impact factor: 25.606

9.  An instructive component in T helper cell type 2 (Th2) development mediated by GATA-3.

Authors:  J D Farrar; W Ouyang; M Löhning; M Assenmacher; A Radbruch; O Kanagawa; K M Murphy
Journal:  J Exp Med       Date:  2001-03-05       Impact factor: 14.307

10.  Chromatin remodeling by the T cell receptor (TCR)-beta gene enhancer during early T cell development: Implications for the control of TCR-beta locus recombination.

Authors:  N Mathieu; W M Hempel; S Spicuglia; C Verthuy; P Ferrier
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

View more
  38 in total

Review 1.  IL-9 and Th9 cells: progress and challenges.

Authors:  Picheng Zhao; Xiang Xiao; Rafik M Ghobrial; Xian C Li
Journal:  Int Immunol       Date:  2013-09-11       Impact factor: 4.823

2.  Neutralization of interleukin-9 ameliorates symptoms of experimental autoimmune myasthenia gravis in rats by decreasing effector T cells and altering humoral responses.

Authors:  Xiuhua Yao; Qingfei Kong; Xiaoli Xie; Jinghua Wang; Na Li; Yumei Liu; Bo Sun; Ying Li; Guangyou Wang; Wenjin Li; Siying Qu; Haijun Zhao; Dandan Wang; Xijun Liu; Yao Zhang; Lili Mu; Hulun Li
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

Review 3.  IL-9 and Th9 cells in health and diseases-From tolerance to immunopathology.

Authors:  Junhui Li; Shuqiu Chen; Xiang Xiao; Yong Zhao; Wenjun Ding; Xian C Li
Journal:  Cytokine Growth Factor Rev       Date:  2017-07-17       Impact factor: 7.638

Review 4.  The development and in vivo function of T helper 9 cells.

Authors:  Mark H Kaplan; Matthew M Hufford; Matthew R Olson
Journal:  Nat Rev Immunol       Date:  2015-04-07       Impact factor: 53.106

Review 5.  The symphony of the ninth: the development and function of Th9 cells.

Authors:  Rukhsana Jabeen; Mark H Kaplan
Journal:  Curr Opin Immunol       Date:  2012-02-22       Impact factor: 7.486

Review 6.  Th9 and other IL-9-producing cells in allergic asthma.

Authors:  Sonja Koch; Nina Sopel; Susetta Finotto
Journal:  Semin Immunopathol       Date:  2016-11-17       Impact factor: 9.623

7.  An Lck-cre transgene accelerates autoantibody production and lupus development in (NZB × NZW)F1 mice.

Authors:  R K Nelson; K A Gould
Journal:  Lupus       Date:  2015-09-18       Impact factor: 2.911

8.  Th9 cell development requires a BATF-regulated transcriptional network.

Authors:  Rukhsana Jabeen; Ritobrata Goswami; Olufolakemi Awe; Aishwarya Kulkarni; Evelyn T Nguyen; Andrea Attenasio; Daniel Walsh; Matthew R Olson; Myung H Kim; Robert S Tepper; Jie Sun; Chang H Kim; Elizabeth J Taparowsky; Baohua Zhou; Mark H Kaplan
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

9.  Gcn5 is required for PU.1-dependent IL-9 induction in Th9 cells.

Authors:  Ritobrata Goswami; Mark H Kaplan
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

10.  The ETS Family Transcription Factors Etv5 and PU.1 Function in Parallel To Promote Th9 Cell Development.

Authors:  Byunghee Koh; Matthew M Hufford; Duy Pham; Matthew R Olson; Tong Wu; Rukhsana Jabeen; Xin Sun; Mark H Kaplan
Journal:  J Immunol       Date:  2016-08-05       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.